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Several human renal cell carcinomas with X;autosome translocations have been reported in recent years. The t(X; I )(p 11.2;q21) 
appears to be a specific primary anomaly, suggesting that tumors with this translocation form a distinct subgroup of RCC Here 
we report two new cases, one with a t(X;IQ)(pl I.2;q23), the other with a t(X ;l)(p l I.2;p34). The common breakpoint in 
Xpl 1.2 suggests that they belong to the above-mentioned subset of RCC. Using FISH in conjunction with X-spedfic YAC 
clones, we demonstrate that the two new cases exhibited distinct breakpoints within Xpl 1.2. Genes Chromosom Cancer 
/ 4:43 —50 ( 1995). © 1995 Wiley-Liss, inc.
Jong and coworkers in 1986 in a case of RCC in a 
2-year-old boy. In addition, three other cases of 
RCC have been published (Yoshida et al., 1985; 
Tomlinson et al., 1991; Ohjimi et al., 1993), two 
containing X;autosome translocations (Yoshida et 
a l ,  1985; Tomlinson et al., 1991) and one with a 
del(X) (Ohjimi et ah, 1993), again with breaks in 
Xpl 1.2. This suggests that tumors carrying Xpl 1.2 
anomalies represent a new subgroup of RCC.
We present two new cases of RCC carrying 
translocations involving Xpl 1.2. Using FISH in 
conjunction with Xpl 1.2-specific YAC clones, we 
determined the relative locations of the Xpl 1.2 
breakpoints in these tumors. T he  results obtained 
were compared with data from the literature, and 
attempts were made to correlate the different 
breakpoints with tumor histology.
M A TER IA LS A N D  M ETH O D S
Patient Material and Cytogenetic Analysis
T h e  first patient was a 52-year-old male who 
presented with a 12 cm diameter RCC in the left 
kidney. T h e  tumor had a papillary growth pattern 
(Fig. lb), but also showed distinct clear cell fea­
tures (Fig. la). T he  second patient was a 77-year- 
old male with a 3 x 2  cm RCC in the left kidney.
This tumor was of the chromophilic papillary type, 
grade II. Both tumors were classified according to 
Thoenes et al. (1986).
Received December 12, 1994; accepted April 19, 1995.
Address reprint requests to T. Dijkhuizen, Department of Med­
ical Genetics, University of Groningen, Antonius Deusinglaan 4, 
9713 AW Groningen, T h e  Netherlands.
© 1995 Wiley-Liss, Inc.
IN T R O D U C T IO N
Renal cell carcinomas (RCCs) arise from tubular 
epithelium. T h e  incidence of RCC peaks in the 
sixth decade of life (Medeiros and Weiss, 1990). 
Approximately 70% of the patients are males. This 
disparity between the sexes is even more striking 
when the tumor occurs at an early age.
Cytogenetic and molecular genetic investigation 
of RCC has revealed consistent karyotypic abnor­
malities corresponding to the different histologic
RCC subtypes (Kovacs et al., 1991; Kovacs, 1993; 
Van D en Berg et al., 1993). A deletion of the short 
arm of chromosome 3 occurs in the clear cell type, 
which is the most common type of RCC. Also, a 
(partial) trisomy of chromosome 5, especially the 
5q22-qter segment, is frequently found in the clear 
cell tumors. A different set of abnormalities is 
found in the chromophilic (or granular), tubulopap- 
illary tumors. Instead of 3p and 5q aberrations, this 
subtype is characterized by combinations of gain of 
chromosomes 7 and 17 and loss of the Y chromo­
some, together with additional copies of chromo­
somes 12, 16, and/or 20. Renal oncocytoma shows 
loss of the Y chromosome in combination with loss 
of chromosome 1. Recently, a subset of oncocyto­
mas was described with abnormalities involving 
11 q 13 (Van D en Berg et aL, 1994). In the chro­
mophobic tumor type, loss of the Y chromosome 
and loss of chromosomes 1, 6, 14, 15, and 22 may 
be found. In addition, telomeric associations are 
observed in this subtype.
Meloni et al. (1993) described four cases of pap­
illary RCC in which a t(X;l)(pll.2 ;q21) was ob­
served, in one case as the sole abnormality. This 
unique translocation had first been described by de
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Figure I. Case I showing the clear cell features of this tumor with areas of (a) a compact (solid) growth pattern and
(b) a papillary growth pattern» HE, 480 X,
Fresh representative samples of both tumors 
were submitted for cytogenetic investigation. Part 
of the tissue was cultured for 5-7  days in RPMI 
1640 supplemented with FCS (16%), glutamine, 
and antibiotics. T he  cultures were harvested and 
chromosome preparations were made according to 
standard cytogenetic techniques. T he  chromo­
somes were G-banded using trypsin, and karyo­
types were described according to the ISCN 1991.
Fluorescence In Situ Hybridization
All fluorescence in situ hybridization (FISH) 
procedures on metaphase cells were essentially as 
described previously (De Leeuw et aL, 1994b). 
The probes used were: the centromere X-specific 
alphoid sequence probe pBamXS, the OATL1 YAC 
#2, and the OATL2 YAC #7. Ail probes were la­
beled with either biotin-11-dUTP (Sigma, St. 
Louis, MO) or d igoxigenin-lldU TP (Boehringer 
Mannheim, Germany) using a nick-translation kit 
(GIBCO Life Technologies, Gaithersburg, MD). 
T h e  labeled DNA was precipitated in the presence 
of sonicated herring sperm DNA (50-fold concen­
tration). In the case of the YACs, a 50-fold amount 
of sonicated total human DNA was coprecipitated 
for preannealing purposes. This  mixture was dis­
solved in 6 fxl of a hybridization F D S T  solution 
(50% v/v deionized formamide, 10% w/v dextran 
sulphate, 2 x  SSC, 1% Tween-20, pH 7.0), Prior 
to hybridization, the probe was denatured at 80°C 
for 10 min, chilled on ice, and incubated at 37°C 
for 4 hr (200 ng YAC DNA per reaction), allowing 
preannealing. In the case of centromeric probes, no 
preannealing was performed and the probe concen­
tration was 10 ng per hybridization. Metaphase
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cells were prepared using standard procedures. 
T h e  slides were pretreated with RNase A (100 
fxg/ml in 2 X  SSC at 37°C for 1 hr). Subsequently, 
the slides were denatured in 70% formamide, 2 X 
SSC, pH 7.0, at 70°C for 2 min and incubated with 
the probes under an 1 8 x l8 -m m  coverslip in a 
moist chamber for 2 days.
Immunocytochemical detection of the hybridiz­
ing probes was achieved using FITC-conjugated 
avidin (Vector Laboratories, Burlingame, CA; 
1:500 diluted) followed by a two time amplification 
using rabbit an ti-F IT C  (Vector Laboratories; 1:250 
diluted), and mouse anti-rabbit conjugated F IT C  
in the case of biotinylated probes (green signals). 
For digoxigenin probes, rhodamine-conjugated 
sheep anti-digoxigenin (Boehringer Mannheim; di­
lution 1:20) was used followed by Texas Red-con­
jugated donkey anti-sheep (red signals) (Jackson 
Immunoresearch, West Grove, PA; dilution 1:100). 
T he  slides were mounted in antifade medium (9 
parts 2.3% w/v di-azobicyclo-(2,2,2)-octane, 
DABCO, Merck, Darmstadt, Germany, in glycerol 
and 1 part 0.2 M TRIS/HC1, pH 8.0) containing 
4,6-diamino-2-phenylindole (DAPI, 0.5 (xg/ml, 
Sigma) for counterstaining of the chromosomes.
Slides were viewed under a Zeiss Axiophot epi- 
fluorescence microscope equipped with appropri­
ate filters for the visualization of F ITC , rhoda- 
mine/Texas Red, and DAPI fluorescence as well 
as the simultaneous visualization of F IT C  and 
Texas Red fluorescence (Omega double band pass 
filter, Brattleboro, VT). Separate digital images 
(for Texas Red, F IT C , and DAPI, respectively) 
were recorded using a Photometries high-perfor­
mance CH250/A cooled CCD-camera interfaced 
onto a Macintosh Ilci computer. T h e  images were 
superimposed and displayed in red-green-blue 
pseudocolors on the computer screen using the im­
age analysis and processing software program BDS- 
image (Biological Detection Systems, Rockville, 
MD). Photographs were made from the computer 
screen on Kodak E PP  100 Plus colorslide film us­
ing a Polaroid Quickprint.
R E S U L T S
Banding Analysis
A total num ber of 10 cells were analyzed from 
case 1. E ight cells showed a balanced translocation 
involving chromosomes X and 1, as well as other 
changes, giving the karyotype 51,Y,t(X; 1 )(pl 1.2; 
p34), + 5 ,d e r (6 ) t ( l ;6 ) (q l l ;q l l ) ,  +  7, +8 , +11, +  20 
(Fig. 2a).
Eleven cells were analyzed from case 2. T h e
karyotype was 52 ,-Y ,t(X ;10)(p ll.2 ;q23),+ 3 ,+ 5 ,  
+ 7 ,+7 ,4 -12 , H-16, +17  (Fig. 2b). T h e  constitu­
tional karyotype of both patients was 46,XY.
FISH Analysis
Two CMT-specific YACs, one corresponding to 
the 0ATL1 (YAC #2; insert size 500 kb) cluster 
and the other corresponding to the OATL2 (YAC 
#7; insert size 600 kb) cluster on the human X 
chromosome, were used. Metaphase spreads of 
both tumors were analyzed with these YACs in 
conjunction with FISH. T he  results of the FISH 
analyses are given in Figure 3. In case 1, all se­
quences contained within YAC # 2  were translo­
cated to chromosome 1 in the X; 1-translocation 
(Fig. 3c), whereas all sequences contained within 
YAC # 7  were retained on the X chromosome (Fig. 
3d). T h e  breakpoint of case 1 is, therefore, distal to 
the 0ATL2 locus and proximal to the OATL1 locus 
(Fig. 4). For case 2, ail sequences contained within 
YAC # 2  and YAC # 7  were retained on the X chro­
mosome (Fig. 3a,b), indicating that the X;10-trans- 
location in this case was distal to the OATLl locus
(Fig. 4).
D ISC U SSIO N
T he  cytogenetic and histologic data of all cases 
of RCC with X;aucosome translocations are sum­
marized in Table 1. Histologically, most of the 
cases were described according to the WHO clas­
sification, They include four papillary tumors 
(Meloni et al., 1993), one clear cell tumor (T om ­
linson et al., 1991), and one metastasis of a papil­
lary tumor (Ohjimi et al., 1993). Three of the cases 
were classified according to the criteria proposed
by Thoenes and Storkel (De Jong et al., 1986; the 
present two cases). Two of them revealed a papil­
lary growth pattern with distinct clear cell features, 
whereas the third tumor (case 2) was a chro- 
mophilic tubulopapiliary RCC. T he  remaining 
case was published by Yoshida et al. (1985) but 
lacks a description of the pathologic findings.
Cytogenetic analysis revealed a t(X;l)(pl 1.2; 
q21) in five of ten cases (De Jong et al., 1986; 
Meloni et al., 1993), in two of them as the sole 
anomaly. This led to the conclusion that these tu­
mors might represent a new cytogenetic subtype of 
RCC, especially since this abnormality has never 
been described in any other malignancy. T h e  other 
cases exhibited a t(X;l)(pll.2 ;p34) (Yoshida e t  al., 
1985; our case 1), a t(X;17)(pll.2;q25) (Tomlinson 
et al., 1991), a t(X;10)(pll.2;q23) (our case 2), and 
a del(X)(pll) (Ohjimi et al., 1993).
T h e  common denominator in cases of RCC with
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Figure 2. a: One of the metaphases of case I revealing the 51 ,Y,t(X; I )(p 11.2;p34), + 5,der(6)t( I ;6) 
(q 1I ;q 11), + 7, + 8, + 11, + 20 chromosomal pattern, b: One of the metaphases of case 2 revealing the 
52,—Y,t{X;l 0)(p 11.2;q23), + 3, + 5, + 7, + 7, + 12, + 16, + 17 chromosomal pattern.
X;autosome translocations is the breakpoint in 
X pll .2 ,  suggesting an important role for this region 
in tumor development. Cytogenetically, a similar 
breakpoint in X p ll .2  has been observed in 
synovial sarcoma, with the specific translocation 
)(p ll .2 ;q ll .2 ) .  Recently, D eL eeuw and  Su-
ijkerbuijk (De Leeuw  et al., 1993, 1994a; Suijker- 
buijk et al., 1993) mapped two alternative X p l l .2  
breakpoints in these neoplasms to the 0ATL1 and 
the 0ATL2  regions, respectively, using FISH and 
Xp 11.2-specific YAC clones. T h e  genes at the 
OATL1IOATL2 regions as well as those at 18q 11.2:
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Figure 3 . FISH on case 2  (a,b)- and case I (c.d)-derived metaphase ceils using a paint for chromosome 
1 0  (a; green), 0 /\TU (YAC2  (b,c;grcen) or OA7 1 2  YAC7  (d; green), in conjunction with the chromosome 
X centromere probe (b; red), the chromosome ! centromere probe (c; red), or a combination of chro­
mosome I and X centromere probes (d; red), a: The normal 1 0 , the der(IO) and the der (X) are marked 
by a large arrowhead, a small arrowhead, and an arrow, respectively, b: The der (X) is marked by an arrow. 
c,d: The chromosome I centromeres are marked by arrowheads, whereas the YAC signals are indicated by 
arrows. In b and d, the X centromeres (red) arc not marked. Chromosomes arc counterstained in blue
(DAPI).
have recen tly  b e e n  c lo n ed  ( ( 'la rk  e t  al.» 1904; D e
»
L e e u w  et a l,,  1995).
In o rd e r  to d e te r m in e  the  relative b reak p o in t  p o ­
sitions at. X p l  1.2 in tiie R ( .!('s, (bur eases (Suijker- 
buijk  e t a l. ,  1993, and  the  p re sen t  two eases) were 
e x a m in e d  w ith  th e  0 /177,/ and 6M 77J -sp ee if ic
the (JiVI'U  and proximal to the OAT I, I region (Su- 
ijkerbuijk  e t  a!., 1993). Surprisingly, the relative 
b reak p o in t  o f  at least one  of the  p resen t two eases 
appears  to be d iffe ren t. In case 2, it is located distal 
to both the 0 /177,/ and O ATl.J. in ease 1 the  rel­
ative b reak p o in t  is distal to the  OA'i'12 and proxi-
YA(.«'s and  o th e r  p ro b es  (S inke  et ai., 1093; Suijk- mal to the  OAI I J  region, i. he ^A (! #7  signal, 
e rb u ijk  e t  a h ,  1993). 'T he  exam ina tion  o f  the first-
two eases rev ea led  a b re a k p o in t  location distal to
which was previously  found to be split by the trans- 
location in R( !( !s wi th a t ( X; l ) ( p l  l . 2; q 21) (Sui jk-
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Figure 4. Diagram representing the short arm of the X  chromosome and the relative locations of the 
different breakpoints in Xp 11.2 (arrows); SS I and SS2, two alternative synovial sarcoma-associated break­
points; X; I *, t(X; I )(p 11.2;q21 ) breakpoint observed in papillary renal cell carcinoma; X; I and X; 10, two 
breakpoints corresponding to the new cases reported here.
TABLE I. Histologic and Cytogenetic Data of RCC With X;Autosomal Translocations
Case Age (yr) Histology Karyotype
De Jong et al., 1986 
Tomlinson et al., 1991 
Ohjimi et a!.f 1993
Yoshida et al., 1985 
Meloni et al., 1993
This series
1
2
3
4
2
I
24
68
55
24
52
77
Clear cell; papillary + compact 
Clear cell; alveolar 
Metastic RCC; papillary
RCC; granular + papillary (G4) 
RCC; papillary (G3)
RCC; papillary (G3)
RCC; papillary
Clear cell; papillary + compact (G2) 
Chromophllic; papillary (G2)
46,Y,t(X; I )(p 11,2;q21 )
46,Y,t(X;l7)(pl I.2;q25)
45,Y,del(X)(pl l),del(l I)(q23?),add 
(I3)(pll), + add(13)(pll),add(l6)
(p ii),-17,-18
46,Y,t(X; 1 )(p 11 -2;p34.1 )
49,Y,t(X; I )(p I 1.2;q21 ), + 7, + 15, + 17 
41 ,Y,t(X; I )(p 11.2;q21 ),i( 1 )(q 10),der 
(3)t(3; 13)(p 12;q 12),-4.-5,inv(7) 
(qll.2p22),~9-10-11,-13, 
add( 16), + 17,4-18, + 20/40,idemY
45,Y,t(X; 1 )(p 11,2;q21 ), — 22
46,Y,t(X; I )(p 11,2;q21 )/46,idem,inv 
(I3)(ql2q22)
51 ,Y,t(X; l)(p 11.2;p34)f + 5,der(6)t 
(li6 )(q ll;q l!)l + 7, + 8,+ l l t + 20 
52, - Y,t(X; 10)(p 11.2;q23)t + 3, + 5,
+ 7,+ 7,+ 12,4* 16,4-17
erbuijk et al., 1993), is retained on the X chromo­
some in case 1.
Since X p ll .2  contains various cross-hybridizing 
low copy repeated motifs (Sinke et al., 1993), the 
breakpoint in case 1 may be similar to the one 
found by Suijkerbuijk et al. (1993). This suggests
that there is a subtype of RCC with this specific 
X p l l .2  breakpoint, possibly with a distinct histol­
ogy, involving both clear cell features and a papil­
lary growth pattern.
Case 2 was a chromophilic tubulopapillary RCC 
without any clear cell features, and had, besides
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the X pl 1.2 translocation, a chromosomal pattern 
frequently associated with this subtype (Van Den
Berg et al., 1993), i.e., - Y , +  7 ,+  7, + 12,+ 16,
and +17 . Moreover, the FISH results indicate that 
the breakpoint in this case was located distal to the 
OATL1 region, whereas the breakpoints in the 
other three cases examined with FISH are located 
between the OATL1 and OATL2 regions. In this 
case the X p l  1.2 translocation might be coinciden­
tal.
Alternatively, distinct sequences may be in­
volved in the development of specific subsets of 
renal tumors, analogous to the findings in synovial 
sarcoma. In these sarcomas, two related regions in 
Xpl 1.2 are involved in the translocation with chro­
mosome 18. This alternative involvement seems to 
correlate with two histologic subtypes of this neo­
plasm. Biphasic synovial sarcomas display a break 
predominantly in the OATL1 region, whereas the 
monophasic subtype appears to be associated with
the OATL2 region (De Leeuw et al., 1994b, 1995).
It is tempting to speculate that in RCC the break­
point differences may also reflect subtle differ­
ences in tumor histology. T h e  other cases were 
classified according to the criteria of the WHO 
(Mostofi e t  al., 1981), and the cell type is not men­
tioned. Reexamination of these cases, using the 
classification of Thoenes and Storkel (Thoenes et 
al., 1986), might reveal histologic patterns similar 
to that of our case 1.
An interesting finding is that four of ten patients 
with an RCC carrying an X;autosome translocation 
were of relatively young age (1, 2, 24, and 24 years 
old). Overall, the incidence of RCC increases with 
age. In all of these young patients, except one, the 
X;autosome translocation was the sole aberration, 
indicating its crucial role in tumorigenesis. T h e  
fourth case, published by Ohjimi et al. (1993), had 
a del(X) and was a metastasis. T h e  additional chro­
mosomal abnormalities found by the authors are 
probably a reflection of the metastatic potential of 
this tumor. T h e  case described by Yoshida et al. 
(1985) also had t(X; 1) as the sole aberration, but 
the age of the patient was not provided.
T hus  far, all RCCs with Xpl 1.2 abnormalities 
have developed in male patients. Whether or not 
an X-linked tumor suppressor gene is involved, as 
proposed by Tomlinson et al. (1991) and Meloni et 
al. (1993), is not clear. T h e  fact that all of the cases 
developed in males should perhaps not be over­
rated since 70% of all cases of RCC occur in males 
and, including the present cases, only ten cases 
have yet been published. RCC in male patients 
frequently shows loss of the Y chromosome. This is
especially true for the chromophilic (papillary) 
type, in which Y chromosome loss is found in 84% 
of cases (Kovacs et al., 1994). In the cases of RCC 
with Xpl 1.2 abnormalities, Y chromosome loss is 
found in only 20% of the cases. This percentage 
closely resembles the findings in clear cell RCC, in 
which the Y chromosome is lost in 22% of male 
patients. There  might be a relation between this 
observation and the finding of at least three tumors 
with distinct clear cell features.
In conclusion, RCCs with a breakpoint in 
Xpl 1.2 may represent a new subtype of RCC with 
a distinct histology and an aberrant age distribu­
tion. A more detailed description of the pathologic 
findings of these neoplasms, in addition to the ex­
act determination of the breakpoints and genes in­
volved in Xpl 1.2, might shed light on this subject.
REFERENCES
Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM-L, 
Gusterson BA, Cooper CS (1994) Identification of novel genes, 
SYT and SSX, involved in the t(X;18)(pl 1 .2qll ,2)  translocation 
found in human svnovial sarcoma. Nature Genet 7:502-508.
De Jong B, Molenaar WM, Leeuw JA, Idenburg VJS, Oosterhuis 
JW (1986) Cytogenetics of a renal adenocarcinoma in a 2-year-old 
child. Cancer Genet Cytogenet 21:165-169.
De Leeuw B, Suijkerbuijk RF, Balemans M, Sinke RJ, D c Jong B, 
Molenaar WM, Meloni AM, Sandberg AA, Geraghty M T, Hofker 
M, Ropers HH, Geurts van Kessel A (1993) Sublocalization of the 
synovial sarcoma-associated t(X; 18) chromosomal breakpoint in 
Xpl 1.2 using cosmid cloning and fluorescence in situ hybridiza­
tion. Oncogene 8:1457-1463.
De Leeuw B, Balemans M, Olde Weghuis D, Seruca R, Janz M, 
Geraghty M T , Gilgenkrantz S, Ropers HH, Geurts van Kessel A 
(1994a) Molecular cloning of the synovial sarcoma-specific trans­
location (X;18)(pll .2;ql 1.2) breakpoint. Hum Mol Genet 3:745- 
749.
De Leeuw B, Suijkerbuijk RF, Olde Weghuis D, Meloni AM, Sten- 
man G, Kindblom LG, Balemans M, Van Den Berg E, Molenaar 
WM, Sandberg AA, Geurts van Kessel A (1994b) Distinct Xpl 1.2 
breakpoint regions in synovial sarcoma revealed by metaphase 
and interphase FISH: relationship to histologic subtypes. Cancer
Genet Cytogenet 73:89-94.
De Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A 
(1995) Identification of two alternative fusion genes, SYT-SSX1 
and SYT-SSX2, in t(X;l8){qll.2)-positive synovial sarcomas. 
Hum Mol Genet, in press.
Kovacs G (1993) Molecular differential pathology of renal cell tu­
mours. Histopathology 22:1-8.
Kovacs G, Fuzesi L, Emanuel A, Kung H-f (1991) Cytogenetics of 
papillary renal cell tumors. Genes Chromosom Cancer 3:249- 
255.
Kovacs G, Tory K, Kovacs A (1994) Development of papillary renal 
cell tumours is associated with loss of Y-chromosomc-speciFic 
DNA sequences. J Pathol 173:39-44.
Medeiros LJ, Weiss LM (1990) Renal adenocarcinoma. In Eble JN  
(cd): Tumors and Tumor-Like Conditions of the Kidneys and 
Ureters. New York: Churchill Livingstone, pp 35-70.
Meloni AM, Dobbs RM, Pontes JE, Sandberg AA (1993) Translo­
cation (X;l) in papillary renal cell carcinoma. A new cytogenetic 
subtype, Cancer Genet Cytogenet 65:1-6.
Mostofi FK, Davis CJ, Jr. (1981) Histopathological typing of kidney 
tumours. In: International Histological Classification of Tumors. 
Geneva: World Health Organisation.
Ohjimi Y, Isawaki H, Ishiguro M, Hara IT, Ohgami A, Kikuchi M, 
Kaneko Y (1993) Deletion (X)(pll): Another case of renal adeno­
carcinoma with involvement of Xpl 1. Cancer Genet Cytogenet 
70:77-78.
Sinke RJ, D e Leeuw B, Janssen HAP, Olde Weghuis D, Suijker­
buijk RF, Meloni AM, Gilgentkrantz S, Berger W, Ropers HH, 
Sandberg AA, Geurts van Kessel A (1993) Localization of X chro­
so DÎJKHUIZEN ET A L
mosome short arm markers relative to synovial sarcoma- and renal 
adenocarcinoma-associated translocation break-points. Hum 
Genet 92:350-308.
Suijkerbuijk RF, Meloni AM, Sinke RJ, De Leeuw B, Wilbrink M, 
Janssen HAP, Geraghty MT, Monaco AP, Sandberg AA, Geurts 
van Kessel A (1993) Identification of a yeast artificial chromosome 
that spans the human papillary renal cell carcinoma associated 
t(X;l) breakpoint in X p ll .2 .  Cancer Genet Cvtogenet 71:164— 
169.
Thoenes W, Storkel St, Rumpelt HJ (1986) Histopathology and 
classification of renal cell tumors (adenomas, oncocytomas and 
carcinomas). The basic cytological and histopathological elements 
and their use for diagnostics. Pathol Res Pract 181:125-143.
Tomlinson GE, Nisen PD, Timmons CF, Schneider NR (1991) 
Cytogenctics of a renal cell carcinoma in a 17-month-old child.
Evidence for X p l l .2  as a recurring breakpoint. Cancer G enet  
Cvtogenet 57:11-17.
Van Den Berg E, Van Der Hout AH, Oosterhuis JW, Storkel S, 
Dijkhuizen T ,  Dam A, Zweers H M M , Mensink HJA, Buys 
CHCM, De Jong B (1993) Cytogenetic analysis of epithelial re- 
nal-cell tumors: Relationship with a new histopathological classi­
fication. Int J Canccr 55:223—227.
Van Den Berg E, Dijkhuizen T ,  Storkel S, Brucel de la Riviere G, 
Dam A, Mensink HJA, Oosterhuis JW, De Jong B (1995) Chro­
mosomal changes in renal oncocytomas. Evidence that 
t(5;il)(q35;ql3) may characterize a second subgroup of oncocy­
tomas. Cancer Genet Cytogenet, 79:164-168.
Yoshida MA, Ochi-Takeuchi H, Gibas Z, Sandberg AA (1985) Up­
dating of chromosome changes in renal cell carcinoma. Proc
AACR 26:31.
